Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2011-11-17

EMA Application withdrawn: Desloratadine Krka (desloratadine) — Krka, d.d., Novo mesto

View source ↗

Summary

The EMA withdrew the application for Desloratadine Krka, desloratadine, by Krka d.d., Novo mesto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine Krka (desloratadine)

Snippet

Status: Application withdrawn. Therapeutic area: Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal. MAH: Krka, d.d., Novo mesto. Decision date: 23/09/2011